Logo do repositório
 
Publicação

Current costs of heart failure in Portugal and expected increases due to population aging

2020-01Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorGouveia, Miguel Rebordão de Almeida
dc.contributor.authorAscenção, Raquel Maria Sousa e Silva
dc.contributor.authorFiorentino, Francesca
dc.contributor.authorCosta, João Nuno Marques Parracho Guerra da
dc.contributor.authorBroeiro-Gonçalves, Paula Maria
dc.contributor.authorFonseca, Cândida
dc.contributor.authorBorges, Margarida de Fátima Palma Feria
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblSociedade Portuguesa de Cardiologia | Elsevier
dc.date.accessioned2023-01-13T22:11:58Z
dc.date.available2023-01-13T22:11:58Z
dc.date.issued2020-01
dc.descriptionCopyright © 2019 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.
dc.description.abstractINTRODUCTION AND OBJECTIVES: Heart failure (HF) is a growing public health problem. This study estimates the current and future costs of HF in mainland Portugal. METHODS: Costs were estimated based on prevalence and from a societal perspective. The annual costs of HF included direct costs (resource consumption) and indirect costs (productivity losses). Estimates were mostly based on data from the Diagnosis-Related Groups database, real-world data from primary care, and the opinions of an expert panel. Costs were estimated for 2014 and, taking population aging into account, changes were forecast up to 2036. RESULTS: Direct costs in 2014 were €299 million (39% for hospitalizations, 24% for medicines, 17% for exams and tests, 16% for consultations, and the rest for other needs, including emergencies and long-term care). Indirect costs were €106 million (16% for absenteeism and 84% for reduced employment). Between 2014 and 2036, due to demographic dynamics, total costs will increase from €405 to €503 million. Per capita costs are estimated to rise by 34%, which is higher than the increase in total costs (+24%), due to the expected reduction in the resident population. CONCLUSIONS: HF currently has a significant economic impact, representing around 2.6% of total public health expenditure, and this is expected to increase in the future. This should be taken into account by health policy makers, alerting them to the need for resource management in order to mitigate the impact of this disease.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent9
dc.format.extent756483
dc.identifier.doi10.1016/j.repc.2019.09.006
dc.identifier.issn0870-2551
dc.identifier.otherPURE: 17750095
dc.identifier.otherPURE UUID: bf5b24fc-a7c2-472d-aac6-6a70d2bcc4c1
dc.identifier.otherPubMed: 31973946
dc.identifier.otherWOS: 000525740000002
dc.identifier.otherScopus: 85078638291
dc.identifier.urihttp://hdl.handle.net/10362/147522
dc.language.isoeng
dc.peerreviewedyes
dc.subjectSDG 3 - Good Health and Well-being
dc.titleCurrent costs of heart failure in Portugal and expected increases due to population agingen
dc.typejournal article
degois.publication.firstPage3
degois.publication.issue1
degois.publication.lastPage11
degois.publication.titleRevista Portuguesa de Cardiologia
degois.publication.volume39
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
1_s2.0_S0870255119305943_main.pdf
Tamanho:
738.75 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS - Artigos em revista nacional com arbitragem científica